Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | VideoGame Development | Contact

Irritable-Bowel Syndrome Animations

Medical animation irritable, Syndrome animation, Bowel Disease animations. 3D medical illustration syndrome and medical simulations. Custom 3d illustrations by Tres 3D / Medical Animation Studios located in New Jersey / NYC Tri-State area. Top medical illustration company Tres3d.
Dr Nano
Study Finds Structural Brain Alterations In Patients With Irritable Bowel Syndrome
A large academic study has demonstrated structural changes in specific brain regions in female patients with irritable bowel syndrome (IBS), a condition that causes pain and discomfort in the abdomen, along with diarrhea, constipation or both. A collaborative effort between UCLA and Canada's McGill University, the study appears in the July issue of the journal Gastroenterology...
A Guide For Vaccinating The IBD Patient; Findings On Impact Of Gluten-Free Diet In Adult Celiac Patients
A guide for vaccinating the Inflammatory Bowel Disease patient, and studies looking at the impact of a gluten-free diet on adults with celiac disease and the relationship between cognitive factors and treatment response in patients with functional bowel disorders, like IBS, are among the highlights of the June issue of The American Journal of Gastroenterology...
Lubiprostone Successfully Completes Phase 3 Efficacy Trial In Japanese Patients Suffering From Chronic Idiopathic Constipation
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced that a pivotal phase 3 clinical trial of lubiprostone for chronic idiopathic constipation (CIC) in Japanese patients met its primary endpoint with statistical significance and demonstrated a safety profile consistent with previously reported clinical lubiprostone data...
Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment Of Non-Constipation Irritable Bowel Syndrome
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating...
Symptoms Of Digestive Disorders Alleviated By Probiotic Found In Breast Milk
New research published in the FASEB Journal suggests that Lactobacillus reuteri immediately affects nerves in the gut, explaining how probiotics work Here's another reason to breast feed your baby: Canadian researchers have discovered how a probiotic found in breastmilk reduces or eliminates painful cramping in the gut...
Narrow-Band Imaging A Useful Tool To Detect In Vivo Angiogenesis In IBD Patients
Angiogenesis plays a crucial role in neoplastic and non-neoplastic chronic inflammatory disorders, including inflammatory bowel diseases (IBD). Several reports have shown that blockade of angiogenesis in preclinical models of IBD is a promising new therapeutic approach. Visualize angiogenesis in vivo may represent the first step for such a therapeutic approach...
Can Choir Singing Improve Irritable Bowel Syndrome?
A Swedish investigation has compared choir singing and group discussion in irritable bowel syndrome in the current issue of Psychotherapy and Psychosomatics. Singing in a choir is very popular in the Nordic countries. This activity has been associated with increased longevity, and it induces feelings of relaxation and energy...
Rotavirus Vaccine Greatly Reduces Hospitalizations For Acute Gastroenteritis In Children
Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis. The findings appear in a study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/652403), published in the June 1 issue of The Journal of Infectious Diseases...
Even The Most Severe Symptoms Rapidly Relieved By Self-Directed Behavioral IBS Treatment
Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a University at Buffalo behavioral scientist achieved significant relief within four weeks of beginning treatment...
Researchers Report Mild-Mannered Metabolic Helper Rushes To Fight Invading Viruses
Within cells, an ancient antiviral duo can deliver a one-two knockout to thwart invading viruses, report researchers who have just unmasked the cellular sidekick that throws the first punch. The findings mean scientists must rethink the design of antiviral immunity and how the body fends off viruses of all types, including influenza and HIV...
Lexicon Presents Positive Outcome In IBS Patients Treated With LX1031 And Data Supporting Mechanism Of Action
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana...
Researchers Discover New Genetic Candidates For Irritable Bowel Syndrome
Most people associate serotonin with brain neurology, but over 95 percent of the body's serotonin occurs in the gastrointestinal tract, which has a complex neuronal circuit that has been called "the second brain" of the body. Now a Mayo Clinic research team has identified a number of genetic variants in serotonin genes that impact irritable bowel syndrome or IBS...
Ironwood And Forest Present Positive Linaclotide Results From Two Pivotal Phase 3 Trials In Patients With Chronic Constipation
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) presented Phase 3 clinical trial results assessing the efficacy and safety of the investigational drug linaclotide in patients with chronic constipation (CC)...
Antibiotic Prevents IBS Symptoms For Weeks After Final Dose
A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug...
Patients With IBS Commonly Use Narcotics
Doctors often unnecessarily treat irritable bowel syndrome (IBS) with narcotics, according to a study led by University of North Carolina at Chapel Hill researchers. "This course of treatment is generally inadvisable because it does not improve functional status and may have adverse long term effects," said study lead author Spencer D...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2010
Content Management / Website Design by Tresware